导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 2.90% | 1486/4773 |
| 近一周 | -2.33% | 1821/5462 |
| 近一月 | -4.65% | 2623/5421 |
| 近一季 | -8.87% | 3000/5209 |
| 近半年 | -5.66% | 2921/4920 |
| 近一年 | 8.66% | 1166/4366 |
| 近两年 | 68.11% | 1013/2954 |
| 近三年 | 36.07% | 832/2253 |
| 成立以来 | 62.15% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
2.58% 889/4961 |
16.73% 1533/5312 |
- - |
- - |
| 2025 | 30.02% 1355/4813 |
1.81% 1544/3635 |
1.95% 2001/4076 |
22.79% 1613/4524 |
2.03% 1107/4813 |
| 2024 | 6.65% 1738/3463 |
-2.25% 1338/2808 |
-4.87% 1577/3014 |
15.20% 1790/3129 |
-0.45% 1427/3463 |
| 2023 | -6.04% 804/2656 |
7.00% 618/2280 |
-3.98% 993/2385 |
-4.38% 1130/2515 |
-4.35% 978/2655 |
| 2022 | -17.02% 543/2207 |
-12.20% 584/1919 |
2.26% 1322/2016 |
-9.74% 302/2113 |
2.39% 954/2208 |
| 2021 | 15.97% 288/1822 |
-1.26% 457/1255 |
8.94% 597/1330 |
4.19% 375/1466 |
3.47% 428/1822 |
| 2020 | 18.56% 740/1250 |
-5.20% 403/1028 |
15.00% 523/1067 |
6.27% 861/1164 |
2.33% 997/1184 |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 华富中证港股通创新药指数型发起式A | 1.1464 | 27.24% |
| 嘉实中证港股通创新药指数发起式C | 0.8441 | 26.80% |
| 中欧中证港股通创新药指数发起A | 1.5868 | 26.75% |
| 中欧中证港股通创新药指数发起C | 1.4370 | 26.67% |
| 永赢中证港股通医疗主题ETF发起联接A | 0.8762 | 26.58% |
| 华夏中证港股通医疗主题ETF发起式联接A | 0.8585 | 26.45% |
| 华夏中证港股通医疗主题ETF发起式联接C | 0.8568 | 26.39% |
| 国联中证500ETF联接C VS. 长安沪深300非周期A(740101) |